S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CRL Charles River Laboratories International Inc

165.2048

3.56 (2.21%)

Last Updated: 05:31:14

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Charles River Laboratories Charts.

Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Charles River Laboratories Charts.

Charles River Laboratories International Inc News

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
Wednesday 29 January 2025 (2 days ago) • Business Wire

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
Wednesday 22 January 2025 (1 week ago) • Business Wire

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
Friday 17 January 2025 (2 weeks ago) • Business Wire

Form 8-K - Current report
Wednesday 15 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Tuesday 14 January 2025 (2 weeks ago) • Business Wire

Form 8-K - Current report
Saturday 14 December 2024 (2 months ago) • Edgar (US Regulatory)

Charles River Introduces Global Biotech Incubator Program
Friday 6 December 2024 (2 months ago) • Business Wire

Charles River Laboratories to Present at Evercore ISI Investor Conference
Tuesday 3 December 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Charles River Laboratories to Present at UBS and Jefferies Conferences
Tuesday 12 November 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 November 2024 (3 months ago) • Edgar (US Regulatory)

More Charles River Laboratories International Inc News Articles

Australia And New Zealan...

Australian SE All Ordina...

Commonwealth Bank Of Aus...

AUD vs US Dollar

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions